MedPath

Ferring AG

🇨🇭Switzerland
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

13

NMPA:13

Drug Approvals

Desmopressin Acetate Tablets

Product Name
弥凝
Approval Number
国药准字HJ20140286
Approval Date
Apr 25, 2024
NMPA

Desmopressin Acetate Tablets

Product Name
弥凝
Approval Number
国药准字HJ20140285
Approval Date
Apr 25, 2024
NMPA

Desmopressin Acetate Injection

Product Name
弥柠
Approval Number
国药准字HJ20170093
Approval Date
Mar 17, 2022
NMPA

Triptorelin Acetate Injection

Product Name
达必佳
Approval Number
国药准字HJ20160237
Approval Date
Oct 30, 2020
NMPA

Atosiban Acetate Injection

Product Name
依保
Approval Number
国药准字HJ20160527
Approval Date
Oct 20, 2020
NMPA

Atosiban Acetate Injection

Product Name
依保
Approval Number
国药准字HJ20160183
Approval Date
Oct 20, 2020
NMPA

Atosiban Acetate Injection

Product Name
依保
Approval Number
国药准字HJ20160182
Approval Date
Oct 20, 2020
NMPA

Atosiban Acetate Injection

Product Name
依保
Approval Number
国药准字HJ20160528
Approval Date
Oct 20, 2020
NMPA

Desmopressin Acetate Tablets

Product Name
弥凝
Approval Number
H20140285
Approval Date
Sep 27, 2019
NMPA

Desmopressin Acetate Tablets

Product Name
弥凝
Approval Number
H20140286
Approval Date
Sep 27, 2019
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath